Health ❯ Clinical Research ❯ Randomized Controlled Trials ❯ Testosterone Studies

Health Outcomes

FDA Panel Urges Looser Testosterone Rules, Including Descheduling and Broader Use

The advice is nonbinding, with any label or scheduling changes dependent on later decisions by both agencies.